Breast Early Stage Part 3 Flashcards

1
Q

Give the four Accelerated Partial Breast Irradiation techniques.

A

Multicatheter Interstitial Techniques
MammoSite
External-Beam Conformal Radiation
Intraoperative Partial Breast Irradiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In multicatheter technique:

Total No. of catheters and planes are dependent on the:

A
Total No. of catheters and planes: dependent on the:
 size
extent, and 
shape of the target
Due to complexity:  less widely used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Employs a single balloon catheter introduced into the lumpectomy site either at the time of lumpectomy or percutaneously after the procedure

A

Mammosite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dose of the mammosite?

A

Dose: 3.4 Gy, 1 cm 2x daily (34 Gy for 5 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In APBI,

Over 70% of patients in randomized trial are opting for 3D-CRT due to?

A

Non-invasiveness

Homogeneous Dose Distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Challenges in EBRT APBI?

A

Daily positioning of the target
Movement with breathing
Delivery of higher doses to surrounding normal breast tissue than with the brachytherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dose of EBRT APBI

A

Dose: 38.5 Gy in 3.85 Gy/fx delivered twice daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RT: delivered in a single intraoperative dose to the lumpectomy site at the time of surgery
Intraoperative electrons or intraoperative photons

A

Intraoperative Accerlerated Partial Breast Irradiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the dose for IORT APBI?

A

Single fraction of 21 Gy is equivalent to 60Gy/2Gy/fx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ASTRO Recommendations on suitability of patients receiving APBI?

A
Suitable for patients: (2009)
≥60yrs
Node (-)
Invasive ductal tumors
≤2cm
(-) margins
ER (+)
(-) lymphovascular space involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the four important factors that can affect cosmesis?

A
  1. Surgical factors to be considered include extent of surgical resection, re-excision, orientation and length of the scar, closure or not of the tylectomy cavity, separate or continuous axilla–tylectomy scars, extent of the axillary dissection, and whether an ellipse of skin over the tumor was removed.
  2. Radiation therapy factors are doses to the whole breast with tangential portals, homogeneity of dose throughout the breast (use of wedge or compensating filters), use of bolus, fractionation, overall duration of therapy including breaks, type and dose of boost, beam energy, and volume treated (whether peripheral lymphatic irradiation is administered).
  3. Chemotherapy issues include cytotoxic agents used, timing and sequence relative to radiation therapy, and doses and combinations of drugs.
  4. Host factors include size and shape of the breast, age, race, compliance with care and hygiene, concurrent medical illnesses (e.g., hypertension, diabetes, CVD), and intrinsic sensitivity to radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In surgical aspect what are the factors Associated with lower rates of excellent/good cosmesis:

A

Reexcision of primary site
>100cm3 breast tissue resection
Skin resection area >20cm2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Axillary surgery DOES NOT affect Breast Cosmesis

T or F?

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Radiation factors affecting cosmesis?

A
Treatment volume (tangential breast fields only vs. three fields or more)
Whole breast dose (>50 Gy)
Total dose to the tumor site (>65 Gy)
Optimum dose distribution created with use of compensating filters
NOT FACTORS:
Daily fractions size (1.8 vs 2 Gy)
Boost vs No boost
Use and type of boost  (brachytherapy vs. electrons)
Total irradiation dose
Use of bolus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In EORTC trial, what are the factors showing worse cosmetic outcomes

A
Factors associated with worse cosmesis:
Inferior tumor location
Large excision volume
Presence of postoperative complications
Radiation therapy boost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most frequent findings in imaging after BCS in early stage Breast CA

A

parenchymal distortion and fibrosis
at the tumor excision site (secondary to surgical scar and irradiation)

skin thickening
seen in 90% of patients, which may be diffuse or more prominent at the surgical excision site

calcifications
due to fat necrosis, which are coarse and round and have radiolucent centers

17
Q

drew et al compared MRI vs Mammo and Clin exam

What is the conclusion?

A

CONCLUSION: When combined, clinical examination and mammography are as sensitive as MRI of the breast for the detection of locoregional recurrence, but MRI has greater specificity.

18
Q

Risk of arm edema increases when axillary dissection and axillary radiation therapy are used

What is the most common presentation of lymphedema?

A

Swelling

19
Q

Factors associated with arm edema?

A

More extensive axillary dissection (Beyond Level II - Midline)
Axillary Surgery plus irradiation
Younger women with axillary node dissection
> 13 LN dissected

20
Q

Unusual variant of panniculitis thickened sclerotic septa:
thick and thin collagen bundles
lobular panniculitis

A

Pseudosclerodermatosus panniculitis

21
Q

Tamoxifen has been shown to induce secretion of ________, which has been implicated in pathogenesis of radiation fibrosis.

A

tumor growth factor-β

22
Q

True or false?

Skin effects after postlumpectomy radiation therapy may be affected more significantly by the increase in the dose of radiation per fraction rather than by the total dose

A

True

23
Q

incidence of brachial plexopathy was significantly higher when the axillary dose was ______ Gy

A

> 50 Gy

24
Q

Most common presentation of pneumonitis

A

Dry cough

25
Q

High incidence of pneumonitis seen in?

A

Higher incidence of pneumonitis: paclitaxel (Taghian et al.)

Higher incidence: with concurrent use of weekly paclitaxel (Burstein et al.)

26
Q

Increase cardiotoxicity noted in the concurrent use of RT (left sided) and cardiotoxic regimens

What are some of the cardiotoxic drugs?

A

Adriamycin
Epirubicin
Trastuzumab

Trastuzumab can be used concurrently with Rt

27
Q

Two factors associated with transient ischemic attacks and CVA?

A

Age and hypertension remained significant predictors of cardiovascular accident or transient ischemic attack

28
Q

True or false

By 5 years, the overall cost for breast-conservation therapy was higher than for a mastectomy

A

False

By 5 years, the overall cost for breast-conservation therapy was lower than for a mastectomy

29
Q

Common goal of APBI techniques?

A

GOAL: COMMON STRATEGY

Delivering RT to a smaller vol. of breast tissue around lumpectomy site

Fewer larger fractions, over shorter period of time